-transparent.png){kind=logo}
90 out of 191 patients with bronchial carcinomas were treated exclusively with telecobalt (focal dose ofer 4,500 rad), 78 patients were given an additional treatment with Proresid, and 23 patients were additionally treated with 5-fluorouracil under so-called synchronization conditions. As far as the Proresid is concerned, the combination with the chemotherapy did not bring about an amelioration of the survival rates compared to the results of the radiotherapy alone. The survival rate of the patients treated with cobalt 60 and with 5-fluorouracil even showed a considerable decrease, so that the described combination therapies are not longer used in our institute.
Related Publications
K Hering, and
K Seegelken
July 1962,
Strahlentherapie,
K Hering, and
K Seegelken
December 1973,
Schweizerische medizinische Wochenschrift,
K Hering, and
K Seegelken
January 1962,
Radiologia Austriaca,
K Hering, and
K Seegelken
January 1974,
Les Bronches,
K Hering, and
K Seegelken
September 1959,
Medizinische Klinik,
K Hering, and
K Seegelken
December 1974,
Thoraxchirurgie, vaskulare Chirurgie,
K Hering, and
K Seegelken
October 1976,
Deutsche medizinische Wochenschrift (1946),
K Hering, and
K Seegelken
January 1982,
Archiv fur Geschwulstforschung,
K Hering, and
K Seegelken
January 1986,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
K Hering, and
K Seegelken
January 1990,
Bulletin du cancer,
